A novel platform for cancer therapy using extracellular vesicles.

Area of Science:

• Biotechnology
• Nanomedicine
• Cell Biology

Background:

• Extracellular vesicles (EVs) are nanoscale vesicles mediating intercellular communication.
• EVs carry functional biomolecules like proteins, mRNAs, and microRNAs.
• EVs are being explored as natural drug delivery systems (DDS) due to inherent organ tropism and low toxicity.

Purpose of the Study:

• To provide an overview of methods for utilizing EVs as drug delivery systems (DDS).
• To highlight the potential of EVs in targeted organ delivery.
• To address the need for understanding EV organ tropism mechanisms and optimizing EV collection/preservation.

Main Methods:

• Review of current literature on Extracellular Vesicles (EVs) for drug delivery.
• Analysis of studies demonstrating EV-mediated organ targeting.
• Discussion of methods for EV isolation, preservation, and application in DDS.

Main Results:

• EVs possess natural organ tropism, enabling targeted drug delivery.
• Existing reports show successful drug delivery to specific organs using EVs.
• The precise mechanisms underlying EV organ tropism remain largely undetermined.

Conclusions:

• EVs represent a promising, low-side-effect platform for drug delivery systems (DDS).
• Further investigation into EV organ tropism mechanisms is crucial for optimizing DDS.
• Efficient methods for EV collection and preservation are essential for clinical translation.